Delivery Order SPE2DR25D3103-SPE2DR26F9H27
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,486.78 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit-dose packaging (100 count). This is a firm fixed price, non-set-aside delivery order with a completion date of September 2, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $3,105.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit dose packaging (100 count). This is a non-set-aside award with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement...
- The Defense Logistics Agency awarded a $12,037.36 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit dose packaging (100 count). This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of May 22, 2025. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lansoprazole delayed-release orally disintegrating tablets, a medication used to treat conditions like acid reflux. The contract has a total ceiling value of $5,272.44 and is a firm fixed-price contract with an ultimate completion date of April 29, 2025. This contract is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANSOPRAZOLE DR 15 MG ODT UD 100S, a pharmaceutical product, with a ceiling value of $1,383.35. The contract is a firm fixed price, non-set-aside award with a performance period ending on May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, identified as SPE2DB20D1100|SPE2DB25FZ62G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,751.36, is for the delivery of 4566740533 - Lansoprazole DR 15 MG ODT UD 100S, a prescription medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,397.52 contract is a Firm Fixed Price Delivery Order for the provision of 4,559,437,942 units of Lansoprazole ODT 15 mg Tablet UD 100s. The contract has an ultimate completion date of December 22, 2022 and was awarded on December 21, 2022. This delivery order is placed against AmerisourceBergen's $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,797.99, is for the delivery of Lansoprazole DR 15 MG ODT UD 100S. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a delivery order valued at $14,610.88 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Prevacid DR 30 mg Solutab unit dose tablets (100 count). This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Lansoprazole ODT 30 mg tablets. The award has a ceiling value of $15,791.07 and is a firm fixed price delivery order contract with a period of performance through July 27, 2022. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen holds a larger...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9H27Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,582.87 to AmerisourceBergen Drug Corp for Lansoprazole DR 15 mg Orally Disintegrating Tablets (100 count unit dose) on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lansoprazole is a proton pump inhibitor commonly used to treat gastric acid-related conditions in military healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a pharmaceutical prime vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support Defense Health Agency and other federal healthcare systems globally. The company's status as a major pharmaceutical distributor with an extensive federal contracting portfolio demonstrates its capacity to fulfill diverse medical procurement requirements through competitive federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/20/25 |